A single center, randomized controlled trial on the treatment of elderly patients with acute myeloid leukemia by attack and reinforcement combined with demethylatio
- Conditions
- elderly patients with acute myeloid leukemia
- Registration Number
- ITMCTR2000003828
- Lead Sponsor
- Yueyang integrated traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1. Meet the diagnostic criteria of Western medicine for senile AML;
2. Accord with the diagnostic criteria of TCM syndrome of senile AML;
3. Aged 60 to 80 years old;
4. The patients with an estimated survival time of more than 3 months;
5. Willing to accept the treatment of this program and sign the informed consent.
1. Acute promyelocytic leukemia;
2. Patients with serious organic diseases such as heart, brain, liver and kidney, and patients with other malignant tumors and mental diseases;
3. Coexisting diseases with any significant abnormalities or poor nutritional status, which affect the life safety and compliance of patients;
4. Allergy to any drug involved in the scheme;
5. Participate in other clinical researchers one month before enrollment.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method overall remission rate;
- Secondary Outcome Measures
Name Time Method RD level of bone marrow;Complete remission rate;Quality of life assessment;Quantitative score of TCM Syndromes;